Prime Medicine, founded by David Liu, is finding that the path of translating scientific breakthroughs to treatments is ...

Opinion: “Exposed” by Wendy Kline shows how the pelvic exam exemplifies questions about gender, medicine, and power.

Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs ...

Stanford professor James Zou examined the clinical adoption of medical AI devices, and found that only a handful are being ...

The CDC said an investigation into a human H5N1 bird flu infection in Missouri has found four additional health care workers ...

After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

Dhillon is an instructor in the Division of Global Health Equity at Brigham and Women’s Hospital and Harvard Medical School.

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

What comes next for Pfizer's Oxbryta sickle cell drug —Cassava Sciences' SEC charges —Bristol's new schizophrenia treatment ...

Pandemic-era rules, set to expire Dec. 31, enabled telehealth prescriptions of controlled medications like buprenorphine, ...

MedStar executive Raj Ratwani says the idea of shared responsibility should be central to how health AI is regulated.